mTOR(mammalian target of rapamycin) inhibitor Analog of rapamycin with similar inhibition of mTOR. Inhibited human rhabdomyosarcoma xenograft growth and angiogenesis. Caused G1/S cell cycle arrest in liver cancer cells
Know who made it. See the evidence. Buy through one marketplace.
mTOR(mammalian target of rapamycin) inhibitor
Analog of rapamycin with similar inhibition of mTOR. Inhibited human rhabdomyosarcoma xenograft growth and angiogenesis. Caused G1/S cell cycle arrest in liver cancer cells
This product is manufactured by TriBio Science and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
Mechanistic target of rapamycin kinase (MTOR), commonly called mTOR, is a serine/threonine protein kinase and core component of mTOR signalling complexes. This ABMIUM record connects NCBI Gene 2475 and UniProtKB P42345 to catalogue-backed research products.
Biological function: Mechanistic target of rapamycin kinase (mTOR/MTOR) is the catalytic kinase of mTORC1 and mTORC2. These complexes integrate nutrient, energy and growth-factor signals to regulate processes including protein synthesis, cell growth, metabolism, survival and cytoskeletal organisation.
